Has gene therapy for ALS arrived?

Amyotrophic lateral sclerosis has not responded well in clinical trials to what initially seemed a promising therapy-the administration of neuronal growth and survival factors. Now, a gene therapy-based approach in mice revives hope that proper delivery of such factors can slow the disease's course.